These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 26297360)

  • 1. Remote ischaemic conditioning on recipients of deceased renal transplants, effect on immediate and extended kidney graft function: a multicentre, randomised controlled trial protocol (CONTEXT).
    Krogstrup NV; Oltean M; Bibby BM; Nieuwenhuijs-Moeke GJ; Dor FJ; Birn H; Jespersen B
    BMJ Open; 2015 Aug; 5(8):e007941. PubMed ID: 26297360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remote Ischemic Conditioning on Recipients of Deceased Renal Transplants Does Not Improve Early Graft Function: A Multicenter Randomized, Controlled Clinical Trial.
    Krogstrup NV; Oltean M; Nieuwenhuijs-Moeke GJ; Dor FJ; Møldrup U; Krag SP; Bibby BM; Birn H; Jespersen B
    Am J Transplant; 2017 Apr; 17(4):1042-1049. PubMed ID: 27696662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote ischaemic conditioning and early changes in plasma creatinine as markers of one year kidney graft function-A follow-up of the CONTEXT study.
    Nielsen MB; Krogstrup NV; Oltean M; Nieuwenhuijs-Moeke GJ; Dor FJMF; Birn H; Jespersen B
    PLoS One; 2019; 14(12):e0226882. PubMed ID: 31887168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early remote ischaemic preconditioning leads to sustained improvement in allograft function after live donor kidney transplantation: long-term outcomes in the REnal Protection Against Ischaemia-Reperfusion in transplantation (REPAIR) randomised trial.
    Veighey KV; Nicholas JM; Clayton T; Knight R; Robertson S; Dalton N; Harber M; Watson CJE; De Fijter JW; Loukogeorgakis S; MacAllister R
    Br J Anaesth; 2019 Nov; 123(5):584-591. PubMed ID: 31521337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote ischemic conditioning enhanced the early recovery of renal function in recipients after kidney transplantation: a randomized controlled trial.
    Wu J; Feng X; Huang H; Shou Z; Zhang X; Wang R; Chen Y; Chen J
    J Surg Res; 2014 May; 188(1):303-8. PubMed ID: 24556231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised sham-controlled double-blind trial evaluating remote ischaemic preconditioning in solid organ transplantation: a study protocol for the RIPTRANS trial.
    Uutela A; Helanterä I; Lemström K; Passov A; Syrjälä S; Åberg F; Mäkisalo H; Nordin A; Lempinen M; Sallinen V;
    BMJ Open; 2020 Nov; 10(11):e038340. PubMed ID: 33199419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocol of a randomised controlled, open-label trial of ex vivo normothermic perfusion versus static cold storage in donation after circulatory death renal transplantation.
    Hosgood SA; Saeb-Parsy K; Wilson C; Callaghan C; Collett D; Nicholson ML
    BMJ Open; 2017 Jan; 7(1):e012237. PubMed ID: 28115329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of remote ischemic conditioning on mortality after kidney transplantation: the systematic review and meta-analysis of randomized controlled trials.
    Ko E; Park HY; Lim CH; Kim HJ; Jang Y; Seong H; Kim YH; Shin HJ
    Syst Rev; 2024 Jul; 13(1):201. PubMed ID: 39075595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remote ischemic conditioning may improve graft function following kidney transplantation: a systematic review and meta-analysis with trial sequential analysis.
    Zhang Y; Long Y; Li Y; Liao D; Hu L; Peng K; Liu H; Ji F; Shan X
    BMC Anesthesiol; 2024 May; 24(1):168. PubMed ID: 38702625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote ischemic preconditioning of transplant recipients to reduce graft ischemia and reperfusion injuries: A systematic review.
    Farooqui W; Pommergaard HC; Rasmussen A
    Transplant Rev (Orlando); 2018 Jan; 32(1):10-15. PubMed ID: 28637593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EPURE Transplant (Eplerenone in Patients Undergoing Renal Transplant) study: study protocol for a randomized controlled trial.
    Girerd S; Frimat L; Ducloux D; Le Meur Y; Mariat C; Moulin B; Mousson C; Rieu P; Dali-Youcef N; Merckle L; Lepage X; Rossignol P; Girerd N; Jaisser F
    Trials; 2018 Oct; 19(1):595. PubMed ID: 30376884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
    Orban JC; Fontaine E; Cassuto E; Baumstarck K; Leone M; Constantin JM; Ichai C;
    Trials; 2018 Apr; 19(1):231. PubMed ID: 29665840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin Inhibitor in NEuRoloGically deceased donors to decrease kidney delayed graft function study: study protocol of the CINERGY Pilot randomised controlled trial.
    D'Aragon F; Selzner M; Breau R; Masse MH; Lamontagne F; Masse M; Chassé M; Carrier FM; Cardinal H; Chaudhury P; Weiss M; Lauzier F; Turgeon AF; Frenette AJ; Bolduc B; Ducharme A; Lamarche C; Couture E; Holdsworth S; Bertholz L; Talbot H; Slessarev M; Luke P; Boyd JG; Shamseddin MK; Burns KEA; Zaltzman J; English S; Knoll G; Dhanani S; Healey A; Hanna S; Rochwerg B; Oczkowski SJW; Treleaven D; Meade M;
    BMJ Open; 2024 Jun; 14(6):e086777. PubMed ID: 38871657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
    Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ;
    Trials; 2020 May; 21(1):428. PubMed ID: 32450917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved GFR and renal plasma perfusion following remote ischaemic conditioning in a porcine kidney transplantation model.
    Soendergaard P; Krogstrup NV; Secher NG; Ravlo K; Keller AK; Toennesen E; Bibby BM; Moldrup U; Ostraat EO; Pedersen M; Jorgensen TM; Leuvenink H; Norregaard R; Birn H; Marcussen N; Jespersen B
    Transpl Int; 2012 Sep; 25(9):1002-12. PubMed ID: 22775333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remote Ischemic Conditioning and Renal Protection.
    Giannopoulos G; Vrachatis DA; Panagopoulou V; Vavuranakis M; Cleman MW; Deftereos S
    J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):321-329. PubMed ID: 28443376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote ischaemic conditioning for prevention of acute kidney injury after valvular heart surgery: a randomised controlled trial.
    Song JW; Lee WK; Lee S; Shim JK; Kim HJ; Kwak YL
    Br J Anaesth; 2018 Nov; 121(5):1034-1040. PubMed ID: 30336847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes of kidney transplantation from expanded criteria deceased donors at a single center: comparison with standard criteria deceased donors.
    Hwang JK; Park SC; Kwon KH; Choi BS; Kim JI; Yang CW; Kim YS; Moon IS
    Transplant Proc; 2014; 46(2):431-6. PubMed ID: 24655981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potassium canrenoate in brain-dead organ donors: a randomised controlled clinical trial protocol (CANREO-PMO).
    Belarif L; Girerd S; Jaisser F; Lepage X; Merckle L; Duarte K; Girerd N; Guerci P
    BMJ Open; 2023 Oct; 13(10):e073831. PubMed ID: 37821131
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.